Johnson & Johnson company sentenced for marketing powder that causes ovarian cancer

The company has been the subject of lawsuits accusing it of failing to warn consumers of the cancer risks from asbestos in their powder. The group has said that their talc did not contain asbestos and did not cause cancer.

An appeals court in the United States confirmed the verdict that the talc sold by Johnson & Johnson causes ovarian cancer and sentenced the American pharmacist to pay 2.1 billion dollars in damages, according to reports on Wednesday (06.24.2020).

The Missouri Court of Appeals decision cut in more than half the $ 4.4 billion that a jury had awarded to 22 plaintiffs and their families in 2018. The court found that some of the plaintiffs should not have been included in the process because they came from from out of state. But the June 23 decision upheld the damages to be paid by the pharmaceutical and hygiene products group for "knowingly selling asbestos-containing products to consumers."

"Because the defendants are large multi-million dollar corporations, we believe that a significant amount of punitive damages is necessary to have an effect in this case," the Court noted. "It is impossible to attribute monetary value to the physical, mental, and emotional distress that the plaintiffs suffered from the harm inflicted by the defendants," he added.

The plaintiffs claimed that Johnson & Johnson's use of powder for their intimate cleansing had caused ovarian cancer. A company spokeswoman stated that the company would appeal the decision to the Missouri Supreme Court, according to the Wall Street Journal.

Johnson & Johnson has been the subject of thousands of lawsuits in recent years accusing him of failing to warn consumers of the cancer risks from asbestos in his talcum powder, and he was convicted multiple times for that matter. The group has always claimed that their baby powder was asbestos-free and cancer-free.

In May, the company announced that it was no longer selling this talc-based powder in the United States and Canada, countries where sales declined due to changing habits and consumer mistrust of the product. However, the company will continue to sell it in the rest of the world.